Memory formation is the most important aspect of a vaccine which can guarantee long-lasting immunity and protection. The main aim of the present study was to evaluate the memory immune responses after immunization with a mini vaccine. Mice were immunized with human immunodeficiency virus-1 P24-Nef fusion peptide and then cellular and humoral immune responses were evaluated. In order to determine long-lived memory, immune responses were monitored for 20 weeks after final immunization. The results showed that the candidate vaccine induced proliferation and cytotoxic T lymphocyte responses and shifted cytokine patterns to T helper-1 profile.
aking an efficient human immunodeficiency virus-1 (HIV-1) vaccine is still a puzzle in today's world. Even though many candidate vaccines were developed to fight against this infection, but none of them have yet displayed any protective effect in human clinical trials (1) (2) (3) .
HIV-1 vaccines in experimental trial are targeting broad CD8+ cytotoxic T lymphocyte responses with the hope that they can prevent or reduce initial viral burden after infection and dissemination of virus from mucosal sites into the systemic circulation (4) . Current studies have concentrated on multi-epitopic vaccines with highly immunogenic properties (5) . Utilizing immuno-genic and conserved epitopes from the critical proteins of HIV-1 is a viable approach to attain an M Submmited 28 September 2015; Accepted 9 December 2015; Published 26 December 2015 immunogenic and effective immune response (5, 6) .
Herein, clustering of epitopes from different parts of structural and regulatory proteins of HIV particle could be of use (7, 8) . The construction of immunodominant epitopes from HIV-1 is a strategy that could enable a strong stimulation of humoral and cellular immune responses. As a result, now it is accepted that targeting of both humoral and cellular immune responses are needed for induction of protection against HIV infection (9) . The critical role of CD8+ T cells in control of viral replication in human and non human primate models is unavoidable (10) . In fact, the control of viral load initially needs the induction of strong cytotoxic T lymphocyte responses (10, 11) . Targeting of the cytotoxic T lymphocyte (CTL) response to certain epitopes of HIV proteins has been shown to be useful in controlling infection (12) . Studies in HIV infected patients show that CTL responses directed against HIV P24 and Nef proteins, correlate with disease progression and the intensity of the immune response is directly linked to the prevention of illness progression (13) . Nef is a regulatory protein and has a key role in viral replication, pathogenicity and escape from immune responses. Analyzes of HIV sequences revealed that this protein, as well as P24, has multiple conserved and immunogenic epitopes that are recognized by cytotoxic and T helper lymphocytes (14) (15) (16) (17) . So, considering those properties and bioinformatic analysis results, fusion of P24 and Nef for candidate vaccine design was considered (9) . Herein, a fusion peptide candidate vaccine based on the most conserved and immunogenic sequences in proteins from HIV P24 and Nef were used as a model to study the lasting of immune responses. Here, for the first time we have shown that immunization of mice with a mini vaccine could generate long-lived memory responses, as it was sustained 20 weeks after the final shot.
Material and methods

Peptide
HIV-1 P24-Nef fusion peptide from P24 (aa 159-173 ) and Nef (aa 102-117 ) with a three amino acid linker comprising AAY (alanine-alanine-tyrosine) was synthesized (EPFRDYVDRFYKTLRAAYHS-QRRQDILDLWIYHT) according to the solidphase method by GL Biochem Company (Shanghai, China) with purity >95%. Peptide was resolved in sterile phosphate buffer saline in a final concentration of 5 mg/ ml and stored at -70 ˚C until use. 
Cell Line
ELISA of specific antibodies and isotypes
Statistical analyzes
The data were expressed as Mean± SD. All statistical analyzes were done by one-way ANOVA followed by Tukey's test. In all of the cases, P value less than 0.05 was considered to be statistically significant. 
Results
Lymphoproliferative activity
Lymphocyte proliferative responses were 
Cytotoxic activity
The CTL response was monitored, as a key mediator in the control of HIV infection. To detect cytotoxic activity, Granzyme B ELISPOT method was used. Analysis of GrB producing cells revealed that peptide immunization of mice increased this population compared to control groups (P=0.0001) in 50:1 of E:T ratio (Fig. 2) . Monitoring of cytotoxic activity of mice immunized with P24-Nef peptide after 20 weeks revealed a decrease in CTL activity over time but significant differences were observed between immunized and control groups (P=0.0001) and no significant difference was observed between control groups (P>0.05). 
IL-4 and IFN-γ assay
Humoral immune responses and isotyping
Humoral immune response was determined with indirect ELISA method. The results of total antibody titration showed that immunization of experimental groups with adjuvanted P24-Nef fusion peptide induced specific antibody (Fig.4a) responses. The peak of specific IgG antibody level was observed at weeks 4 (P= 0.0001) and 12 (P= and II contributed to the efficient stimulation of immune response and memory formation (19, 20) .
Here we evaluated a fusion peptide as a candidate vaccine in BALB/c mouse model and monitored immunologic parameters for memory analysis. We did not conjugate the peptide with keyhole limpet hemocyanin (KLH) or BSA because of immunomodulatory effect of conjugation (21) and did not utilize complete Freund ' s adjuvant for immunization because of the polarization effect on specific immune responses (22, 23) . 
